Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefadroxil Granules

Approval Number

国药准字H19991095

Company贵州汉方制药有限公司

Registration Date

December 3, 2019

Drug Information

Generic Name

头孢羟氨苄颗粒

Trade Name

毅达

Brand Name

毅达

Dosage Form

颗粒剂

Strength

0.125g(按C16H17N3O5S计)

Drug Type

化学药品

Registration Date

December 3, 2019

Company Information

Applicant Company

Company Name贵州汉方制药有限公司

Manufacturing Company

Company Name贵州汉方制药有限公司

Company Address

贵阳国家高新区息烽医药工业园汉方路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

头孢羟氨苄颗粒 - NMPA 批准文号 | MedPath